Oragenics Inc (OGEN): Shareholders' Equity
$8.28M
As of 2025-12-31
$3.67M
As of 2026-06-30
-14.0%
3-year compound annual growth
-13.2%
5-year compound annual growth
+5.8%
10-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $8.28M | n/m | 2026-03-16, Balance as of period end |
| 2024-12-31 | -$211.9K | n/m | 2026-03-16, Balance as of period end |
| 2023-12-31 | $3.17M | -75.6% | 2025-03-14, Balance as of period end |
| 2022-12-31 | $13.01M | -50.9% | 2024-03-29, Balance as of period end |
| 2021-12-31 | $26.49M | +57.2% | 2023-04-17, Balance as of period end |
| 2020-12-31 | $16.84M | -2.2% | 2022-07-29, Balance as of period end |
| 2019-12-31 | $17.23M | -17.5% | 2021-03-01, Balance as of period end |
| 2018-12-31 | $20.88M | +230.6% | 2020-03-04, Balance as of period end |
| 2017-12-31 | $6.32M | +113.0% | 2019-03-29, Balance as of period end |
| 2016-12-31 | $2.97M | -37.3% | 2018-02-16, Balance as of period end |
| 2015-12-31 | $4.73M | -54.2% | 2017-02-27, Balance as of period end |
| 2014-12-31 | $10.34M | -34.7% | 2016-03-30, Balance as of period end |
| 2013-12-31 | $15.84M | +71.6% | 2015-02-27, Balance as of period end |
| 2012-12-31 | $9.23M | n/m | 2014-02-28, Balance as of period end |
| 2011-12-31 | -$8.18M | n/m | 2013-03-26, Balance as of period end |
| 2010-12-31 | -$1.90M | n/a | 2012-04-16, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Oragenics Inc (OGEN) | 2025-12-31 | $8.28M | n/m |
| Medicus Pharma Ltd. (MDCX) | 2025-12-31 | $37.3K | -98.8% |
| Korsana Biosciences, Inc. (KRSA) | 2025-12-31 | $9.09M | +2.7% |
| Genprex, Inc. (GNPX) | 2025-12-31 | $7.96M | +391.4% |
| Longeveron Inc. (LGVN) | 2025-12-31 | $5.67M | -74.1% |
| Cocrystal Pharma, Inc. (COCP) | 2025-12-31 | $6.33M | -33.5% |
| MAIA Biotechnology, Inc. (MAIA) | 2025-12-31 | $2.38M | -34.6% |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | 2025-12-31 | $2.25M | +217.9% |
| FibroBiologics, Inc. (FBLG) | 2025-12-31 | $6.16M | +125.1% |
Compare OGEN, MDCX, KRSA, GNPX side by side · Screen every company in Pharmaceutical Preparations ↗